Tag: Cancer: Rectal
Beans Beneficial for Patients With History of Colorectal Neoplasia
Increase in diversity and shifts in multiple bacteria, including Faecalibacterium, indicative of prebiotic efficacy on intervention
MSI-H Colorectal Cancer Rarely Recurs After Immunotherapy Cessation
88 percent of 64 patients remained without disease progression after median of 22.6 months after stopping immunotherapy
Risk for CRC Reduced With GLP-1RAs for Drug-Naive Patients With T2D
GLP-1 receptor agonists linked to reduced risk for CRC compared with other antidiabetics, including insulin and metformin
Colorectal Screening Rates Do Not Differ by 10-Year Life Expectancy in Seniors
Authors say that screening based on individual life expectancy, rather than age, may improve screening selection and value
Recent Decline in Risk for CRC Recurrence Seen in Stage I to III Disease
Patients with stage III disease had a shorter time from surgery to recurrence than those with stage I disease
>10 Percent of FIT Are Unsatisfactory and Cannot Be Processed
Fewer than half of those with an unsatisfactory FIT completed a subsequent test within 15 months
Type 2 Diabetes Linked to Increased Risk for Colorectal Cancer
Greater associations seen for those without colonoscopy screening, with smoking history, and for recent diabetes diagnosis
Receipt of Guideline-Concordant Care Lower for Black Colorectal Cancer Patients
Disparity explained by health insurance among those with colon and rectal cancer
Advanced Neoplasia Risk Increased at Upper Range of Negative FIT Values
At fecal hemoglobin cutoff of 17 µg/g, sensitivity and PPV were 39 percent and specificity and NPV were 93 percent
Risk-Adapted Starting Age of CRC Screening Varies by Sex, Genetics
Risk-adapted starting age of screening varies by 24 years for men in highest polygenic risk score decile versus women in lowest
